Click here for Analysts' Upgrades, Downgrades.

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

Abercrombie & Fitch

(ANF) - Get Report

numbers raised through 2012 at Citigroup. Company continues to see healthy comp sales growth.

Carnival

(CCL) - Get Report

price target increased at Citigroup to $56. Company should see improving pricing power, Citigroup said. Buy rating.

Cintas

(CTAS) - Get Report

estimates raised through 2012 at Citigroup. New clients are driving sales growth, Citigroup said. Hold rating and $29 price target.

Danaher

(DHR) - Get Report

price target raised at Citigroup to $56. Company has an upbeat outlook for the new year, Citigroup said. Buy rating.

Medtronic

(MDT) - Get Report

price target boosted to $47 at Citigroup. Company has new management and should benefit from a higher industry multiple. Buy rating.

Nike

(NKE) - Get Report

2011 and 2012 EPS estimates lowered at Credit Suisse to $4.35 and $4.85, respectively. 150-basis-point margin pressure due to cost inflation, Credit Suisse said. Maintain Outperform rating and $100 price target.

Nike

(NKE) - Get Report

estimates, target boosted at Morgan Stanley. Shares now seen reaching $94. Estimates are also upped, as strong futures orders are driving increased earnings visibility, Morgan Stanley said. Overweight rating.

Paychex

(PAYX) - Get Report

price target raised to $29 at Credit Suisse. Solid 2Q11 results and optimistic outlook, Credit Suisse said. Estimates raised through 2013. Maintain Neutral rating.

Red Hat

(RHT) - Get Report

price target raised to $48 from $36 at Barclays. Broad strength is driving third-quarter billings upside, Barclays said. 2011 and 2012 EPS estimates lifted to $0.79 and $0.95, respectively. Maintain Equal Weight rating.

Riverbed Technology

(RVBD)

price target boosted at Barclays to $50 from $40. Another beat-and-raise story, and robust demand continues, Barclays said. Reiterate Overweight rating.

Texas Instruments

(TXN) - Get Report

numbers raised at UBS. Shares now seen reaching $32. Estimates also increased, given better demand for smartphones and communications infrastructure. Neutral rating.

UnitedHealth Group

(UNH) - Get Report

target, estimates boosted at Credit Suisse. Price target raised by a dollar to $48. 2010 and 2011 EPS estimates lifted to $4.05 and $3.75, respectively. Weaker cost trends, and selloff on RADV Audit overdone, Credit Suisse said. Maintain Outperform rating.

Xilinx

(XLNX) - Get Report

estimates lowered at UBS through 2013. Company is seeing a delay in European orders. Neutral rating and $28 price target.

This article was written by a staff member of TheStreet.